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Summary
Aging is a process which operates at many levels of physiological, genetic and molecular or-
ganization and leads inevitably to death [18]. Brain macroscopic changes by MRI investigation 
during aging were observed in humans and dogs but chimpanzees did not display significant 
changes. This suggestion led to the statement that brain aging is different in various species. 
Although human brain changes, e.g. β-amyloid storage, neurofibrillary tangle formation, li-
pofuscin, are relatively well known, we are still looking for a suitable animal model to study 
the mechanisms of aging and neurodegenerative diseases. Therefore, this paper presents 
a comparative analysis of the changes described in the brains of senile dog, horse and gorilla. 
In addition we present the latest, non-invasive methods that can be applied in the diagnosis 
of old age in mammals. Our considerations have shown that the best animal model for further 
studies and observations on aging is the dog.
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IntroductIon
Various changes develop with age in the nervous system 
of man and animals. Lesions such senile plaques, cerebral 
β-amyloid angiopathy, neurofibrillary tangles, corpora 
amylacea and mineralization appear with advancing age 
in the human brain but are not specific to the human 
brain. In the brains of aged dogs, horses and nonhuman 
primates similar changes have been reported frequently 
[30]. These species may therefore serve as animal models 
for investigating e.g. β-amyloidosis in Alzheimer’s disease 
[35]. However, comparable data on the effects of brain ag-
ing in humans and chimpanzees differ from each other 
in several ways [28]. Therefore we hypothesized that in 
spite of mutual features in senile brain, there are spe-
cies-dependent differences between animals and humans. 
According to us, the knowledge about the differences 
between species is important to find alternative animal 
models of human aging to study disability-free longevity, 
not just the addition of years. For this purpose we moni-
tored morphological neurological changes in brains of 
dogs (living in the same environment as people), horses 
(which acquire many of the same diseases that plague 
humans) and primates (close relatives of humans) to cor-
roborate the usefulness of natural animal models for the 
study of normal aging and neurodegenerative diseases.
theorIes of agIng
Biological, epidemiological, and demographic data have 
generated a number of theories that attempt to identify 
a cause or process to explain aging and its inevitable con-
sequence, death. However, in recent years, the search for 
a single cause of aging, such as a single gene or the decline 
of a key body system, has been replaced by the view of ag-
ing as an extremely complex, multifactor process. Several 
processes may interact simultaneously and may operate 
at many levels of functional organization [32]. Attempts to 
classify theories of aging have led to two major categories: 
programmed aging and wear and tear aging. Programmed 
aging is aging due to something inside an organism’s con-
trol mechanisms that forces elderliness and deterioration 
–similar to the way genes programme other life stages 
such as cell differentiation during embryological devel-
opment or sexual maturation at adolescence. By contrast 
aging due to wear and tear is not the result of any specific 
controlling programme, but is the result of the sum effect 
of many kinds of environmental assaults, damage due to 
radiation, chemical toxins, metal ions, free radicals, hydro-
lysis, glycation, disulfide-bond cross-linking, etc. For many 
organs – particularly the brain, heart, lung and kidney – 
specific disease states associated with aging are of more 
significance than generalized deterioration. There is wide 
Fig. 1. Brain; 14-month rat, β-amyloid deposition in pyramidal layer of cortex, Congo-red stain (author’s own research)271
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variation in the health status of specific organs among the 
elderly [1]. In the aging brain many signs of deterioration 
have been observed. We grouped them, and described the 
morphological changes below.
MacroscopIc changes
Few macroscopic changes were observed in old dogs com-
pared with young controls. Narrowing of gyri and wid-
ening of sulci were evident in some of the oldest dogs 
together with an increase in ventricular volume. These 
changes are well known in humans but rarely reported in 
animals. Both cerebral atrophy and ventricular enlarge-
ment have been related to the loss of cortical neuronal 
populations in elderly people. Whether this is also true 
in animals is unknown, but selective loss of neurons has 
been described by several authors for a variety of spe-
cies. Although a quantitative analysis of neuronal loss 
was not performed, satellitosis and neuronophagia were 
found in dogs; neuronophagia was a clear indication of 
neuronal loss [3].
aMyloId (corpora aMylacea)
β-amyloid (Aβ) deposition in brain is a progressive age-
related process beginning with diffuse deposits of im-
munologically cross-reacting proteins in the deep cor-
tical layers followed by the development of deposits 
in other parts of the cortex [26,29,30]. Aβ structure is 
visible in light microscopy after staining with Congo 
red, cresyl violet, PAS reaction and by fluorescence and 
immunofluorescence microscopy [Fig. 1]. The various 
forms of Aβ are classified biochemically according to 
the protein precursors. To date, 25 different amyloid 
protein precursors (APP) have been identified [10]. The 
extracellular Aβ in brain is generated by enzymatic 
processing of APP. Overexpression of APP as seen in 
Down syndrome and induced mutations in transgenic 
mice may lead to early onset of Alzheimer’s disease 
(AD). Aβ is deposited in the cerebral vessel walls and 
in the brain cortex as senile plaques (SPs) accumulat-
ing on and between the membranes of degenerating 
neural structures and an abundance of microglia and 
astrocytes [5,25,26]. Aβ- positive staining was found 
in the brains of 8.5-year-old dogs and in older dogs 
revealing vascular staining and plaques. Corpora am-
ylacea (CA) have been observed in an albino gorilla 
(Gorilla gorilla gorilla) throughout the brain but with 
topographic predilection for the periventricular white 
matter, hippocampus, medial temporal cortex, medulla 
oblongata, and, more abundantly, the pars reticulate 
of the substantia nigra (SN). CA from the SN and hip-
pocampus were smaller than those found in the rest of 
the gorilla’s brain. Most of the CA found in the gorilla 
had accumulations of ubiquitin and microtubule-as-
sociated proteins similar to CA accumulated in human 
aging. However, CA located principally in the hippo-
campus and SN in the gorilla were almost all negative 
to both these proteins and mostly had accumulations of 
phosphorylated neurofilaments and α-synuclein [16]. 
tau and neurofIbrIllary tangles 
Tau is a microtubule [MT]-associated protein stabilizing 
microtubules as tracks for axonal transport [19]. Neu-
ronal microtubules play a central role in axonal growth 
and development by providing a structural framework 
for new axons by serving as substrates for membrane 
vesicle transport in the axon and stabilize microtubules 
against depolymerization. In brain, the expression and 
activity of tau are known to change during development. 
The immature brain tau proteins are a closely spaced 
doublet at 48 kDa, while adult brain tau is considerably 
more heterogeneous, with at least three prominent dou-
blets. Tau appears to be only a single gene from which 
diversity is generated by both alternative splicing and 
posttranslational modifications, such as phosphorylation 
[23,24]. In degenerating neurites hyperphosphorylated 
cytoskeleton protein, tau and also ubiquitin have been 
encountered. Both are major components of paired he-
lical filaments (PHF) in AD brains and lead to dementia. 
Polymerization of tau into PHF and binding of ubiquitin 
initiate neurofibrillary tangle (NFT) formation. Ubiquitin 
is a small heat shock protein involved in the degenera-
tion of altered cytoplasmic proteins (target proteins for 
nonlysosomal ATP-dependent proteolysis). There is in-
creasing concern about the role of ubiquitin in relation 
to NFTs [26]. Ubiquitin-positive immunoreactions were 
detected as granules and globules of various sizes in white 
matter of all old dogs but never in young control dogs. 
The density of ubiquitinated bodies increased with age. 
Immunoreactive bodies appeared among axonal fibres 
and were seen only occasionally in glial cells or neurons. 
A primary myelin disorder inducing increased levels of 
abnormal proteins or a decreased proteolytic rate has 
been proposed to explain the presence of these ubiqui-
tinated bodies [3]. In dogs tau was detected in neurons 
of the hippocampus and cortex of the parietal lobe. The 
positivity was located in the cytoplasm as granules and 
in the axon processes as threads. The positive neurons 
resembled those in human brains during the early stage 
of tauopathy [26]. 
lIpofuscIn
Lipopigments are cytoplasmic pigments that have an af-
finity for neutral lipid stains. They are classified as those 
that occur normally in tissues (lipofuscin) and those gen-
erated experimentally or associated with pathological 
conditions (ceroid) [8]. Lipofuscin, or age pigment, is an 
autofluorescent material which accumulates progres-
sively with age within secondary lysosomes in long-lived 
postmitotic cells of man and animals. For all we know 
lipofuscin is a conglomerate of lipids, metals (iron, alu-
minium, copper), organic molecules and biomolecules 
[4,20]. Typically, lipofuscin stains well with oil red O, Su-
dan black, acid fast, and PAS stains [Fig. 2]. A variety of 
studies indicate that lipofuscin formation and accumu-
lation within the lumen of secondary lysosomes is fun-
damentally linked to the hydrolytic activity within lyso-
somes. Intracellular digestion of substances taken into  Fig. 1. Brain; 14-month rat, β-amyloid deposition in pyramidal layer of cortex, Congo-red stain (author’s own research)272
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the cell by endocytosis occurs primarily in lysosomes, 
as does the degradation of molecules and organelles of 
the cytoplasm constantly targeted and removed by au-
tophagy. Also, lipofuscin-overloaded lysosomes might be 
unable to further handle peroxidized material formed 
during oxidative stress, which would increase the intra-
cellular concentration of lipid peroxidation, such as malo-
ndialdehyde, impairing critical cellular functions. [2,12]. 
Intraneuronal lipofuscin deposits were observed also in 
horses and the quantity of the pigment and the number 
of areas affected increased with age. In young horses, in-
traneuronal lipofuscin was largely confined to the mes-
encephalic trigeminal nucleus, the red nucleus, and the 
vestibular nucleus. In other equine studies, the olivary 
nucleus and the pyramidal cells of the cortex were the re-
gions affected in young horses. However, it was suggested 
that the anatomical distribution of lipofuscin is related to 
the activity of the nuclei. Age-related glial and neuropil 
lipofuscin deposition in horses were confined to the ros-
tral part of the brain. Lipofuscin deposition is caused by 
intracellular accumulation of cell debris after autophagic 
lysosomal degeneration. Finding this pigment in neuro-
pil may be the result of occasional exocytosis. Another 
theory is that glial cells containing lipofuscin pigment 
become pyknotic and die, and afterward only extracel-
lular deposit can be observed [13]. Lipofuscin storage was 
present in aged dogs, with a wide distribution in cerebral 
cortex, basal nuclei, thalamus, hippocampal pyramidal 
neurons, cerebellar dentate nuclei, and some midbrain 
nuclei. Although lipofuscin in young control dogs ap-
peared as small perinuclear and granular deposits, old 
dogs had more diffuse granular deposits affecting the 
pericardia and proximal dendritic tree [3].
Vascular changes
Vascular age-related changes in CNS include: thicken-
ing, fibrosis, hyalinosis of small arteries, calcification of 
the tunica externa of blood vessels and choroid plexus, 
microhaemorrhages and Aβ in small blood vessels of the 
cerebral cortex (cerebral amyloid angiopathy). The most 
prominent change observed in old dogs was fibrosis of 
the vessel walls. Adventitial thickening showed a focal 
distribution in most cases, affecting both meningeal and 
parenchymal (especially thalamic) vessel walls and being 
more frequent in small-diameter veins than arteries. This 
change seemed to have a variable age distribution but was 
more marked in 14- and 15-year-old dogs. Other vascular 
abnormalities were hyalinosis and microhaemorrhages. 
Hyalinosis affected the tunica media of some arterioles, 
but there were no other associated vascular or perivas-
cular lesions. Vascular changes were also observed in go-
rilla brain and were characterized by thickening, fibrosis 
and hyalinosis of small arteries. Diffuse microspongiosis, 
Fig. 2. Brain; 14-month rat, lipofuscin in Purkinje cells of cerebellum, PAS stain (author’s own research)273
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which was more accentuated in perivascular spaces, was 
observed throughout the nervous parenchyma [16]. The 
hyalinized vessel walls in brain of horses could not be 
established. However, age-related vascular changes have 
been described in humans consisting of thickening of ves-
sel walls, fibrosis and hyalinization [13].
Mineralization in the wall of CNS blood vessels occurs 
most commonly in aged humans (atherosclerosis), but 
is also found in animals. In the CNS of aged horses it was 
observed to affect parenchymal blood vessels, especially 
in the dentate nuclei and globus pallidus, internal capsule 
and caudate nucleus, and not to pertain to generalized 
vascular diseases. In elderly people, a mild degree of cal-
cification inside and around blood vessels is a common 
incidental finding in the cerebral grey or white matter, 
without associated symptoms [15]. The morphology and 
histochemistry of cerebral mineralization in monkeys 
closely resembled those of human cases commonly found 
in the globus pallidus. In monkeys no neurological symp-
toms or signs were recognized, as observed in humans. 
Because cerebral mineralization induces no clinical signs, 
it might be physiological rather than pathological, as with 
mineralization of the pineal gland or choroid plexus cur-
rently observed in monkeys. In human Fahr’s disease with 
severe mineralization, lesions of the basal ganglia were 
observed on radiographs or with computed tomography, 
showing pathological changes similar to those in mild 
pallidal vascular mineralization [34].
Cerebrovascular amyloidosis was detected in old dogs, 
affecting leptomeningeal and parenchymal medium and 
small calibre arterioles and capillaries. Amyloid pro-
tein was also deposited in the external tunica media of 
vessel walls [35]. Congophilic material was detected in 
some small blood vessels of the cerebral cortex in go-
rilla brain [16].
spheroIds
Axonal dystrophy and spheroids are hallmarks of CNS 
axon pathology [17]. Spheroids were shaped as round or 
oblong eosinophilic structures of variable size, between 
15 μm and 30 μm in diameter, strongly stained with Biel-
schowsky stain. Immunohistochemical studies showed 
ubiquitin, α-β-crystallin, tau, and 200 KDa neurofilament 
accumulation within the spheroids. Perls’ method clearly 
revealed iron deposition in the neuropil and within some 
spheroids. Increased neuromelanin pigment was also ob-
served in this area. The accumulation of neurofilaments 
indicates that at least part of the accumulated material 
inside the spheroids comes from the degraded neuronal 
cytoskeleton. Tau accumulation in spheroids would in-
dicate an attempt to repair the axonal damage. The α-β-
crystallin overexpression in spheroids would protect ax-
ons from the aggregation of intermediate filaments and 
proteins triggered by iron-mediated oxidative stress. The 
ubiquitin immunostaining of spheroids would indicate 
activation of the proteolytic nonlysosomal system for 
the degradation of abnormal filamentous cytoskeletal 
proteins. Dystrophic axons are usually smaller swellings 
often associated with continuity of the axon. One or both 
of these aberrant axon morphologies are found in a wide 
range of neurodegenerative disorders, including stroke, 
myelin disorders, tauopathies, amyotrophic lateral scle-
rosis, traumatic brain injury, AD, Creutzfeldt-Jakob dis-
ease, HIV dementia, hereditary spastic paraplegia and 
Niemann-Pick disease. They also occur during normal 
ageing and secondarily in some serious illnesses. More-
over, in nonhuman primates, pallido-nigral spheroids 
associated with iron deposition have been observed in 
clinically normal gorillas as a normal aging phenome-
non [16]. In some instances in horses, the spheroids were 
associated with coalescing vacuoles in the surrounding 
grey and white matter, and some spheroids were also 
vacuolated. Spheroids were common in the brainstem 
particularly in the nucleus funiculus lat. [13]. In aged 
dogs spheroids were seen in cerebral grey matter and, 
more frequently, in cerebral white matter (cortical ra-
diations, corona radiate and capsula interna). Spheroids 
were negative for neurofilament immunostaining, and 
only occasional ubiquitin-positive immunoreactions were 
seen. This differential staining may indicate a different 
pathogenic mechanism, the former being a consequence 
of altered axonal retrograde transport and the latter be-
ing the result of a defect of normal cellular catabolism [3].
other changes
Neuronal, neuropil and white matter vacuolation has 
been reported in the nervous system of a few domestic 
species [11,13]. In the horse, the main involved areas of 
neuronal vacuoles were the mesencephalic trigeminal 
nucleus, the Purkinje cells and the neurons in the raphe 
at the level of the obex. Neuropil vacuolation contributes 
significantly to clinically detectable reduced neuronal 
function and was linked with autolysis, which may predis-
pose brain tissue to artefactual vacuolation. The oculomo-
tor nucleus was the main site affected by neuropil vacu-
olation in horses. White matter vacuolation in the horses 
occurred mainly in the internal capsule of the basal gan-
glia. Vacuolation of white matter has been associated 
with congenital and acquired degenerative diseases, but 
the most commonly attributed reasons include hepatic 
encephalopathy and uraemia, where the vacuolation is 
distributed at the junction of grey and white matter [13].
Glial changes affected mostly astrocytes. Astrogliosis was 
seen in old dogs, but astrocytosis (increased number of 
astrocytes) was observed only in a few dogs. These glial 
changes were diffuse, bilateral, and more prominent in 
white than in grey matter, mainly in the corticomedullary 
junction, corpus callosum, capsula interna, hippocampus, 
and other cerebellar white matter. Isomorphic gliosis was 
seen in cerebellar Bergman’s glia in old dogs [3]. Gliosis 
was also seen in horses in the cerebrum and in an aged al-
bino gorilla throughout the nervous parenchyma [13,16].
Polyglucosan bodies (PGB) were detected in many areas, 
mainly as free neuropil inclusions affecting all aged dogs 274
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but not young controls. The term PGB refers to several 
different inclusion bodies composed mainly of glucose 
polymers. Lafora bodies and CA are the two main PGB 
reported in aged dogs. Ultrastructural canine brain stud-
ies have determined the intraneuronal location of Lafora 
bodies, in both cytoplasm and axons, whereas CA are as-
trocytic inclusions. Positive ubiquitin immunoreactions 
have also been described. Lafora bodies may have no overt 
neurological consequences in aged dogs, but their con-
tribution to cognitive dysfunction syndrome needs more 
detailed study, especially considering that a disorder simi-
lar to Lafora body disease in humans has been described 
in young dogs, with antecedents of epilepsy, depression, 
or somnolence [3]. 
dIagnostIc Method
Traditional investigations of brain aging were based on 
histological or immunohistological staining. Today inter-
esting applications which have revolutionised medical di-
agnosis are MRI and MRS, available for the ante-mortem 
investigation of various histological types of aging brain. 
MRI depends on the magnetic properties of some nuclei, 
most notably the protons in the hydrogen atoms of wa-
ter, and was developed from its parent technique NMR 
spectroscopy, which is widely used in chemical analysis. 
Soft tissue contrast originates mainly in differences in 
the relaxation properties of the nuclei in different tis-
sues, rather than in the smaller (about 15%) differences 
in water content [21,22,27]. MRI white matter hyperinten-
sity has been reported in brains of aged dogs as well as in 
humans. The appearance of white matter hyperintensity 
is a common manifestation of vascular dementia and is 
connected with cerebral amyloid angiopathy [6]. We ap-
ply this cost-effective MRI technique for investigation of 
macroscopic age changes in brain which were observed 
in humans and dogs.
MRS looks back to the analytical role of NMR, but adds 
spatial localisation, enabling biochemical analysis to be 
done in vivo [21]. The concentrations of most brain me-
tabolites within the neurochemical profile are modified 
during development, reflecting the structural and func-
tional evolution inherent to the differentiation of cerebral 
networks. Therefore, the non-invasively detected neu-
rochemical profile may be taken as a marker for specific 
metabolic states which are associated with degeneration 
or acute injury. Although brain metabolism has wide dif-
ferences among species, namely when comparing rodents 
to humans, once the role of measured neurochemicals is 
understood, high resolution NMR qualifies as the method 
of choice for in vivo investigation of preclinical animal 
models of human neurological and other pathologies dur-
ing development or aging [7]. 1H-MRS can be used to 
assess neuronal loss (with the neuronal marker N-acety-
laspartate) and thus the progress of neurodegenerative 
diseases and their response to therapy can be examined 
[14, 21]. Neurochemical profile detection by 1H-MRS was 
also carried out in antioxidant defence, Huntington’s dis-
ease, Parkinson’s disease, amyotrophic lateral sclerosis 
and Alzheimer’s disease [7].
conclusIons
In the present study we note that several frequently oc-
curring morphological changes were found in aged bra-
ins of dogs, horses and gorillas. Otherwise all changes 
described in the study are similar to those seen in elderly 
people suffering from neurodegenerative disease. Already 
at the beginning of this paper, when analysing macrosco-
pic changes, we drew attention to the similarities of senile 
brain between man and dog. Further discussed changes 
such as Aβ and lipofuscin deposition as well as vascular 
lesions also reflect similarities. Moreover, there are many 
well-documented physiological similarities between dogs 
and humans [31]; therefore tapping into the potential of 
this animal model will add to the existing strengths of co-
nventional model systems. Additionally, it is worth noting 
that the quality of dogs’ lives has improved by enhancing 
veterinary care and hygiene, and using a proper diet, so 
the lifespan has increased similarly to human life. Horses 
and humans have a very similar aging process; both spe-
cies have a tendency to gain weight as they age, which 
can result in an imbalance of hormones [33]. But in the 
case of Aβ deposition in the CNS no changes have been 
observed by scientific research, so it can be eliminated as 
an ideal model to study the neurodegeneration process. 
Monkeys and great apes apparently do not suffer from 
age-related neuropsychiatric illnesses which occur only 
in humans, such as AD. The vast majority of morphologi-
cal studies of brains of aged nonhuman primates indicate 
that very few changes take place during aging. Impor-
tantly, all current studies agree that no decrease in total 
neuron numbers in the cerebral cortex and in subcortical 
structures occurs in nonhuman primates [9]. In addition, 
primates such as gorillas, despite some morphological 
similarities in development of morphological changes in 
the brain and close affinity with humans, live in a com-
pletely different environment compared to humans and 
domesticated dogs. Therefore, this also excludes them 
from the group of animals that may be a perfect model 
for human senile diseases. 275
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